Author:
Lilje Daniel,Thriemer Melanie,Leopold Moritz,Reichert Friedrich
Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Deutsche Gesellschaft für Tropenmedizin RuGGeV S1-Leitlinie Diagnostik und Therapie der Malaria, 7.1, 28.02.2021, Verfügbar unter. https://register.awmf.org/de/leitlinien/detail/042-001. Zugegriffen: 14. Dez. 2023
2. Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD et al (2010) Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 376(9753):1647–1657
3. Sinclair D, Donegan S, Isba R, Lalloo DG. Artesunate versus quinine for treating severe malaria. Cochrane Database Syst Rev. 2012 Jun 13;2012(6)
4. Ritter K, Kuhlencord A, Thomssen R, Bommer W (1993) Prolonged haemolytic anaemia in malaria and autoantibodies against triosephosphate isomerase. Lancet 342(8883):1333–1334
5. Roussel C, Ndour PA, Kendjo E, Larreche S, Taieb A, Henry B et al (2021) Intravenous Artesunate for the Treatment of Severe Imported Malaria: Implementation, Efficacy, and Safety in 1391 Patients. Clin Infect Dis 73(10):1795–1804